Assessing myocardial indices and inflammatory factors to determine anxiety and depression severity in patients with chronic heart failure

Figure 1 Post hoc multiple comparisons of significant influencing factors in patients with different levels of anxiety and depression. A: Post hoc multiple comparisons of the left ventricular ejection fraction; B: Post hoc multiple comparisons of the left ventricular end-diastolic dimensions; C: Post hoc multiple comparisons of N-terminal pro-brain natriuretic peptide; D: Post hoc multiple comparisons of interleukin-6; E: Post hoc multiple comparisons of tumor necrosis factor-alpha (TNF-α). ^aP < 0.05, ^bP < 0.01, ^cP < 0.001. A&D: Anxiety and depression; No-A&D: No anxiety and depression symptoms; Mild-A&D: Mild anxiety and depression symptoms; Moderate-A&D: Moderate anxiety and depression symptoms; Severe-A&D: Severe anxiety and depression symptoms; LVEF: Left ventricular ejection fraction; LVEDd: Left ventricular end-diastolic dimensions; NT-proBNP: N-terminal pro-brain natriuretic peptide; TNF-α: Tumor necrosis factor-alpha; IL-6: Interleukin-6.

Figure 2 Post hoc multiple comparisons of Self-Rating Anxiety Scale and Self-Rating Depression Scale scores among different New York Heart Association classes. ^aP < 0.05, ^bP < 0.01. SAS: Self-Rating Anxiety Scale; SDS: Self-Rating Depression Scale.

Figure 3 Dichotomous evaluation of left ventricular ejection fraction, N-terminal pro-brain natriuretic peptide, and interleukin-6 by region under receiver operating characteristics. LVEF: Left ventricular ejection fraction; NT-proBNP: N-terminal pro-brain natriuretic peptide; IL-6: Interleukin-6; AUROC: Area under the receiver operating characteristic curve.